DEGORA: turning heterogeneous published DEG summaries into an inspectable gene-evidence atlas
Methods · 2027-01 · 257 · 76-84
DOI: 10.1016/j.ymeth.2026.10.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods, 2027-01. Verfasst von Eun Young Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Bio-Convergence, Dankook University, Cheonan 31116, the Republic of Korea; MIND-X Superintelligence Con…. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Published tables of differentially expressed genes (DEG tables) can support secondary transcriptomic analyses when expression matrices or variance estimates are unavailable, but they are not consistently deposited in public repositories. DEGORA converts curated DEG tables into a local database that links gene-level evidence to original studies. It standardizes gene identifiers, collapses related contrasts within studies so that each study contributes once, applies fixed heuristic quality weights, and ranks genes by cross-study support and directional concordance. An optional search module identifies potentially reusable tables. We evaluated DEGORA using four human transcriptional programs as positive-control benchmarks, each represented by 2 to 15 publication-level source units and by up to 20 after human microarray sources were added. DEG tables for three programs were generated from publicly available count matrices, whereas those for the fourth were obtained from the original publications. Using RNA-seq evidence, DEGORA recovered 93% of interferon, 59% of endoplasmic reticulum stress, 73% of heat-shock, and 85% of hypoxia markers among the top 100 ranked genes. In three confirmatory datasets, DEGORA showed no consistent ranking advantage over alternative methods applied to the same tables. The same workflow organized published Alzheimer's disease cohort evidence without recomputing differential expression. Across ten evaluated datasets, performance varied with how the input tables were generated. Overall, DEGORA organizes differential expression evidence at the study level and keeps every ranked gene linked to the publications, assays, and reported statistics behind it.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Bio-Convergence, Dankook University, Cheonan 31116, the Republic of Korea; MIND-X Superintelligence Convergence Innovation Lab, Dankook University, Cheonan 31116, the Republ…
- Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul, the Republic of Korea.
- Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, the Republic of Korea; Institute of Health and Environment, Graduate School of Public Health, Seoul Nation…
- Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, the Republic of Korea.
- Institute of Health and Environment, Graduate School of Public Health, Seoul National University, Seoul, the Republic of Korea. Electronic address: frodo21@snu.ac.kr.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Lee, E. Y., Park, J., Lee, J., Kim, S., Choi, K., Lee, J., & Kang, K. (2027). DEGORA: turning heterogeneous published DEG summaries into an inspectable gene-evidence atlas. Methods, 257, 76-84. https://doi.org/10.1016/j.ymeth.2026.10.012
Vancouver
Lee EY, Park J, Lee J, Kim S, Choi K, Lee J, et al. DEGORA: turning heterogeneous published DEG summaries into an inspectable gene-evidence atlas. Methods. 2027;257:76-84. doi:10.1016/j.ymeth.2026.10.012
BibTeX
@article{Lee2027,
author = {Lee, Eun Young and Park, Jihye and Lee, Jeongae and Kim, Sungkyoon and Choi, Kyungho and Lee, Jaehyouk and Kang, Keunsoo},
title = {DEGORA: turning heterogeneous published DEG summaries into an inspectable gene-evidence atlas},
journal = {Methods},
year = {2027},
volume = {257},
pages = {76--84},
doi = {10.1016/j.ymeth.2026.10.012}
}
EUVIMED